Skip to content

Fortress Biotech, Inc.

FBIO FBIOP

CIK 0001429260

← back to feed
Revenue (TTM)
$63.22M
+9.7% YoY Q1 Mar 2026
Net Income (TTM)
$121.13M
+114.8% YoY Q1 Mar 2026
EPS Diluted (TTM)
$2.90
+97.4% YoY Q1 Mar 2026
Gross Margin
4.5%
Q1 Mar 2026
Operating Margin
-116.0%
Q1 Mar 2026
Net Margin
191.6%
Q1 Mar 2026
Free Cash Flow (TTM)
$113.36M
Q1 Mar 2026
Cash
$255.84M
Q1 Mar 2026
Total Debt
$398K
Q1 Mar 2026
Shares Outstanding
82.47M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings